Documents

Ideas Discussions Technicals Forecast Seasonals Options

INmune Bio Inc. SEC filings and other documents

Explore the latest company documents and SEC filings from INmune Bio Inc., including Forms 10-K, 10-Q, 8-K, and other key disclosures. Evaluate financial performance and operational updates to make more informed decisions.

Data partner

Description

Reported date

Form

2025

Q2 2025

Aug 07, 2025

Transcript

Earnings release8-K

Slides

Quarterly report10-Q

Status Update

Jun 30, 2025

Press release

Q1 2025

May 08, 2025

Transcript

Earnings release8-K

Quarterly report10-Q

Corporate Presentation

Apr 03, 2025

Slides

Study Result

Feb 10, 2025

Transcript

2024

Q4 2024

Mar 27, 2025

Transcript

Earnings release8-K

Annual report10-K

Q3 2024

Oct 31, 2024

Earnings release8-K

Quarterly report10-Q

Q2 2024

Aug 01, 2024

Quarterly report10-Q

Earnings release8-K

Q1 2024

May 09, 2024

Quarterly report10-Q

Earnings release8-K

Investor Presentation

Feb 05, 2024

Slides

2023

Q4 2023

Mar 28, 2024

Earnings release8-K

Annual report10-K

Q3 2023

Nov 01, 2023

Quarterly report10-Q

Earnings release8-K

Q2 2023

Aug 07, 2023

Quarterly report10-Q

Investor Presentation

Jul 11, 2023

Slides

Q1 2023

May 03, 2023

Quarterly report10-Q

Earnings release8-K

2022

Q4 2022

Mar 02, 2023

Annual report10-K

Earnings release8-K

Q3 2022

Nov 02, 2022

Quarterly report10-Q

2021

Q4 2021

Mar 03, 2022

Annual report10-K

2020

Q4 2020

Mar 04, 2021

Annual report10-K

2019

Q4 2019

Mar 11, 2020

Annual report10-K

2018

Q4 2018

Mar 29, 2019

Annual report10-K